
FDA Approves First Advanced Anal Cancer Drug as First-Line Treatment
Incyte announced that the FDA has approved Zynyz (retifanlimab-dlwr) as a combination therapy for the treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC) alongside carboplatin and …